The Timing of Longevity: A Researcher’s Journey into Single vs. Split Dosing

Introduction: The Chrono-Pharmacological Awakening

For years, my morning ritual was a study in unexamined orthodoxy.

Alongside my first cup of black coffee, I would methodically consume a carefully curated collection of supplements—a single, daily bolus dose intended to optimize my biology and extend my healthspan.

Nicotinamide Mononucleotide (NMN), resveratrol, fisetin, spermidine—each molecule was chosen based on exhaustive literature reviews and preclinical data.

I was confident in the what of my protocol.

It was the how—and more specifically, the when—that I had taken for granted.

My approach mirrored the dominant paradigm of the supplement industry, one built on the alluring simplicity of the “one-a-day” model, a concept driven more by marketing convenience than by metabolic reality.¹

The moment of intellectual dissonance arrived not with a sudden epiphany, but with a slow-burning question sparked while reviewing a paper on circadian biology for a grant proposal.

The paper detailed the elegant, clockwork precision of hepatic enzyme expression, showing how the liver’s metabolic machinery ramps up and down in a predictable 24-hour rhythm.

A thought struck me with the force of a physical blow: I was dumping a complex cocktail of xenobiotics into my system at the same time every morning, paying no mind to the dynamic state of the very machinery tasked with processing it.

Was I, in my quest for optimization, committing a fundamental error? Was I undermining my entire protocol by ignoring the variable of time?

This question launched me on a journey deep into the fields of pharmacokinetics and, most critically, chronopharmacology.

It became clear that the “one-a-day” approach, while promoting adherence, is a blunt instrument in a field that demands surgical precision.

It treats the human body as a static, unchanging vessel, when in fact it is a symphony of interconnected biological rhythms, all governed by a master clock.⁵

This report documents that personal and scientific journey.

It is an exploration of the principles that forced me to deconstruct and rebuild my supplementation regimen from the ground up.

I came to understand that the decision between a single daily dose and a split-dose regimen is not a simple choice.

Instead, it is a complex calculation, a strategic decision that must be tailored to each specific molecule, dictated by its unique pharmacokinetic properties and the ceaseless, rhythmic ticking of our own internal clocks.

My goal is to demonstrate that optimizing a longevity protocol requires a profound shift in thinking: from a static list of compounds to a dynamic, timed system of delivery designed to work

with our biology, not against it.

Chapter 1: The Body’s Clockwork: A Primer on Chronopharmacology

My initial exploration led me to the fascinating and, in my opinion, criminally underappreciated field of chronopharmacology.

This is the discipline that formally studies how the timing of drug administration impacts a substance’s effects, efficacy, and toxicity, all in relation to the body’s endogenous biological rhythms.⁷

It was here that I found the scientific language to articulate my burgeoning unease.

The body, I learned, is not a simple beaker into which we pour chemicals; it is a meticulously organized temporal landscape.

The Master Clock (SCN) and Peripheral Clocks

At the heart of our temporal organization is a master pacemaker, the suprachiasmatic nucleus (SCN), a tiny cluster of neurons located in the hypothalamus.⁶

Synchronized primarily by the daily light-dark cycle, the SCN acts as the conductor of our circadian orchestra.

It sends out time-of-day signals that coordinate a vast network of peripheral clocks located in virtually every organ and tissue, from the liver and kidneys to the gastrointestinal tract and even our skin.⁵

This means that the very organs responsible for processing the supplements I was so diligently taking are themselves operating on a strict 24-hour schedule.

Their physiological functions—enzyme activity, blood flow, cell permeability, gene expression—are not constant.

They ebb and flow in predictable patterns, creating windows of peak efficiency and troughs of relative inactivity.⁵

This fundamental principle reframed my entire understanding.

The efficacy of any orally administered compound is not solely a function of the dose or the molecule’s intrinsic properties; it is a product of the interaction between that molecule and the

temporal state of the body’s processing machinery at the moment of administration.

Chronopharmacokinetics vs. Chronopharmacodynamics

Within chronopharmacology, two core concepts provided the framework for my new approach: chronopharmacokinetics and chronopharmacodynamics.⁸

These are essentially the two sides of the time-dependent coin, describing how the body affects the drug and how the drug affects the body, respectively, over a 24-hour cycle.

Chronopharmacokinetics: The Rhythms of ADME

Chronopharmacokinetics investigates how our circadian rhythms impose daily variations on the four fundamental processes of drug handling: Absorption, Distribution, Metabolism, and Excretion (ADME).⁸

The evidence for these rhythms is overwhelming and explains why a supplement taken at 8 AM is processed differently than the exact same supplement taken at 8 PM.

• Absorption: The gastrointestinal (GI) tract is a hotbed of circadian activity. Gastric acid secretion, for instance, is not constant; it typically peaks late at night, which can dramatically alter the ionization and solubility of acidic or basic compounds.¹⁷ Furthermore, GI motility and intestinal blood flow are generally higher during our active phase (the morning and afternoon), creating a more favorable environment for rapid absorption, and slower at night during our rest phase.¹⁰ Even the expression of membrane transporter proteins that ferry molecules from the gut into the bloodstream can follow a daily rhythm.¹⁵
• Distribution: Once a compound enters the bloodstream, its distribution is influenced by rhythmic factors like tissue perfusion and plasma protein binding. The concentrations of key binding proteins, such as albumin, fluctuate throughout the day, typically peaking in the morning and reaching a low point during nocturnal rest.¹⁰ This is critically important because only the “free” or unbound fraction of a drug is biologically active. A change in binding protein levels can therefore alter the effective concentration of a supplement at its target site, even if the total amount in the blood remains the same.
• Metabolism: The liver is the body’s primary metabolic clearinghouse, and its functions are profoundly circadian. The activity of the cytochrome P450 (CYP450) family of enzymes, which are responsible for metabolizing a vast number of drugs and supplements, exhibits robust 24-hour rhythms.¹⁷ In rodents, the peak activity of many of these enzymes occurs in the middle of their active (dark) period.¹⁰ This means the rate at which a supplement is broken down and cleared can vary dramatically depending on the time of day it is ingested.
• Excretion: The kidneys, too, follow the master clock’s tempo. Renal blood flow and glomerular filtration rate—key determinants of how quickly substances are cleared into the urine—vary throughout the day.¹⁰ For a compound primarily cleared by the kidneys, this rhythmic fluctuation in renal function directly translates to a time-of-day-dependent elimination rate.

The clinical relevance of these rhythms is not trivial.

In fields like oncology, aligning chemotherapy delivery with the body’s circadian rhythms—a practice known as chronotherapy—has been shown to reduce severe toxic effects by a factor of two to ten and nearly double antitumor efficacy in patients with metastatic colorectal cancer.²¹

If timing can have such a profound impact on potent pharmaceuticals, it stands to reason that it must also play a significant, if perhaps more subtle, role in the efficacy of longevity supplements.

Chronopharmacodynamics: The Rhythms of Sensitivity

Just as the body’s handling of a drug is rhythmic, so too is the target tissue’s response to it.

This concept, known as chronopharmacodynamics or chronesthesy, describes predictable, time-dependent changes in the susceptibility or sensitivity of a biological system to a compound.⁸

This was a particularly powerful revelation for me, as it invalidates the simplistic assumption that maintaining a constant blood level of a supplement will yield a constant effect.

The evidence shows that receptor density, binding affinity, and downstream signaling efficiency can all oscillate over a 24-hour period.¹⁰

For example, the bronchial tree shows a circadian rhythm in its response to beta-agonists, and the skin exhibits a rhythm in its inflammatory reaction to histamine, with a peak at night.¹⁰

This means that a supplement’s effect can be amplified or dampened depending on the receptivity of its target at the time of arrival.

Even with a perfectly constant infusion of a drug, the biological effect can still show a large-amplitude circadian rhythm, as has been demonstrated with the anticoagulant heparin.¹⁰

This led me to a deeper, more integrated understanding.

The emerging field of “chrono-nutrition” posits that the timing of our meals is a powerful synchronizing agent for our peripheral clocks, particularly in the liver and gut.¹⁸

This implies that an optimized supplement protocol cannot be designed in a vacuum; it must be integrated with meal timing.

The body’s response to a supplement is influenced not just by the time on the wall clock, but by its temporal relationship to the feeding/fasting cycle.

Taking a fat-soluble supplement with a high-fat breakfast will produce a different pharmacokinetic profile than taking it with a high-fat dinner, because the GI tract’s response to the meal is layered on top of its own baseline circadian state.

This creates a complex, multi-variable system where supplement timing and meal timing must be co-optimized to achieve the desired biological outcome.

Chapter 2: The Dosing Dilemma: Deconstructing Bioavailability and Half-Life

Armed with a new appreciation for the body’s temporal nature, I realized I had to revisit the fundamentals of pharmacology.

Before I could intelligently apply the principles of chronopharmacology, I needed to master the basic pharmacokinetic parameters that govern how any compound behaves in the body.

These concepts became the essential toolkit for dissecting and evaluating every supplement in my regimen.

Pharmacokinetics 101: The Core Metrics

I focused on four key metrics that, together, paint a picture of a supplement’s journey through the body and are essential for making an informed decision about dosing frequency.

• Bioavailability (F): This is the single most important measure of absorption efficiency. It is defined as the fraction of an administered dose that reaches the systemic circulation in its unchanged, active form.²⁵ When a drug is administered intravenously (IV), its bioavailability is 100% by definition. For orally administered supplements, however,
  F is almost always less than 100%. This reduction is due to two primary hurdles: incomplete absorption from the gut and the “first-pass effect,” where a portion of the absorbed compound is immediately metabolized by the liver before it ever reaches the rest of the body.²⁶ A supplement with low bioavailability requires a higher dose to achieve a therapeutic effect, and its absorption can be highly variable.²⁷
• Biological Half-Life (t1/2​): This is the most critical parameter for determining how often a substance needs to be dosed. The half-life is the time it takes for the concentration of a substance in the blood plasma to decrease by 50%.²⁹ A compound with a short half-life is cleared from the body quickly, while one with a long half-life lingers. A crucial rule of thumb in pharmacology is the “5 half-lives rule”: it takes approximately 4 to 5 half-lives for a drug’s concentration to reach a stable “steady state” with regular dosing, and similarly, it takes about 5 half-lives for the drug to be almost completely eliminated (about 97%) from the body after the last dose.²⁹
• Maximum Concentration (Cmax​) and Time to Peak (Tmax​): Cmax​ represents the highest concentration that a compound achieves in the blood after administration, while Tmax​ is the time it takes to reach that peak.¹⁰ Together, these two parameters describe the speed and magnitude of absorption. A rapid
  Tmax​ and high Cmax​ indicate that the supplement is absorbed quickly and efficiently, producing a sharp peak in concentration. These metrics are vital for understanding whether a supplement can reach a concentration high enough to trigger a desired biological effect.

The Rationale for Dosing Strategies

These pharmacokinetic principles provide the scientific basis for choosing between a single large dose or multiple smaller, split doses.

The choice is not arbitrary; it is a strategic decision aimed at shaping the concentration-time curve of the supplement in the blood to best match its mechanism of action.

• The Case for a Single Daily Dose: The primary appeal of a single dose is convenience, which is a major driver of adherence. From a pharmacological perspective, this strategy is most appropriate for supplements with a long half-life. If a compound’s t1/2​ is 24 hours or more, a single daily dose is often sufficient to maintain a relatively stable steady-state concentration without significant peaks and troughs. This approach is also favored when the therapeutic goal is to achieve a high Cmax​. Some biological pathways are only activated when a signaling molecule surpasses a certain concentration threshold; in these cases, a single, large bolus dose is the most effective way to produce that activating spike.
• The Case for a Split-Dose Regimen: Splitting the total daily dose into two or more smaller administrations is a more complex but often superior strategy, driven by three main considerations:

1. Overcoming a Short Half-Life: For a compound with a short t1/2​ (e.g., 1-4 hours), a single daily dose results in a transient spike in concentration, followed by a long period where the level is too low to be effective. The plasma concentration curve looks like a single mountain peak in a 24-hour flat plain. By splitting the dose (e.g., one dose in the morning and one in the evening), the goal is to create two smaller peaks, effectively broadening the therapeutic window and maintaining a more sustained concentration above a minimum effective level throughout the day.²⁹
2. Bypassing Absorption Saturation: The transport mechanisms that move nutrients from the gut into the bloodstream are not infinite; they can become saturated. Calcium is a classic example. The body can only efficiently absorb about 500-600 mg of elemental calcium at one time.³⁰ Ingesting a single 1,200 mg dose is therefore inefficient, as a large portion will simply pass through unabsorbed. Splitting that dose into two 600 mg portions, taken several hours apart, allows the absorption machinery to recover, resulting in a significantly greater total amount of calcium absorbed over the course of the day.
3. Mitigating Side Effects: Adverse effects, particularly gastrointestinal issues like nausea or diarrhea, are often linked to the peak concentration (Cmax​) of a substance.³¹ A high, sharp spike in concentration can overwhelm the GI tract. By splitting the dose, each administration produces a lower
   Cmax​, which can dramatically improve tolerability and allow a person to consume a higher total daily dose without discomfort.³¹ This is a common strategy for managing the side effects of medications like methotrexate and supplements like high-dose vitamin C or iron.³³

This analysis led me to a more sophisticated view of the dosing problem.

The choice between single and split dosing is fundamentally a trade-off between maximizing the peak concentration (Cmax​) and optimizing the total exposure over time, represented by the Area Under the Curve (AUC).²⁵

The “best” strategy is therefore entirely dependent on the supplement’s specific mechanism of action.

If a supplement acts as a signaling molecule that requires a high-concentration pulse to activate a target (e.g., hormesis), a single dose might be superior.

If, however, it acts as a continuous fuel or cofactor for cellular processes, then a split dose that maintains a more stable steady-state concentration and maximizes the 24-hour AUC might be the more logical approach.

Furthermore, I realized that the half-life itself is not a static number.

It is a dynamic variable influenced by the body’s rhythmic metabolic and excretory processes, as detailed by the principles of chronopharmacology.¹⁰

The rate of liver metabolism and kidney clearance fluctuates throughout the day.

This means a supplement could have a functionally shorter half-life if taken when metabolic enzymes are at their peak (e.g., evening/night for many CYP450 enzymes) and a longer half-life when they are at their nadir.

This adds a fascinating layer of complexity: for a short-half-life compound, maintaining steady levels might require not just splitting the dose, but perhaps splitting it

asymmetrically or adjusting the dosing interval to counteract the body’s own circadian variations in its clearance rate.

Chapter 3: A Tale of Two Molecules: My Evolving Protocol for NMN and Resveratrol

With a solid theoretical foundation in both pharmacokinetics and chronopharmacology, I turned my attention back to my own shelf of supplements.

It was time to move from theory to practice.

I decided to focus my N-of-1 experimentation on the two cornerstones of my longevity protocol: resveratrol and nicotinamide mononucleotide (NMN).

These two molecules, often taken together for their purported synergistic effects, present starkly different pharmacokinetic challenges, making them perfect case studies for applying my newfound knowledge.

My journey became a series of hypotheses, experiments, and data-driven refinements.

3.1 Resveratrol: The Battle Against a Short Half-Life and Poor Bioavailability

Resveratrol is a fascinating, if frustrating, molecule.

Its potential to activate sirtuins and mimic aspects of caloric restriction has made it a star in aging research.³⁵

However, its practical application is severely hampered by two major pharmacokinetic hurdles: exceptionally low bioavailability and a very short biological half-life.³⁶

Studies show that while up to 70% of an oral dose is absorbed, it is so rapidly and extensively metabolized during the first pass through the intestine and liver that less than 1% typically reaches the systemic circulation as free, unchanged trans-resveratrol.³⁸

Furthermore, the half-life of the parent compound is fleeting, estimated to be between 1-3 hours after a single dose, though its metabolites persist for much longer (around 9 hours).⁴⁰

Protocol v1.0 (The Naive Approach)

Initially, I followed the lead of prominent researchers in the field, like Dr. David Sinclair, who reported taking a single 1 gram dose each morning.⁴³

The implicit rationale was to create the highest possible peak concentration (

Cmax​) of resveratrol and its metabolites, hoping this large pulse would be sufficient to activate the target sirtuin pathways.⁴⁴

It was a strategy focused on maximizing the signal’s amplitude.

However, I quickly encountered predictable problems.

First, I experienced mild but noticeable gastrointestinal discomfort, a well-documented side effect of resveratrol at doses exceeding 1 g/day.⁴⁵

Second, and more importantly from a strategic perspective, I couldn’t shake the pharmacokinetic data.

A single morning dose would produce a transient spike that would be largely gone from my system within a few hours.⁴⁰

It felt like a brief flash of light in a long, 24-hour day—a potentially inefficient use of a costly supplement.

Protocol v2.0 (The Split-Dose Correction)

My next iteration was a logical correction based on classic pharmacokinetic principles.

I split the total daily dose, taking 500 mg in the morning and 500 mg in the evening.

My hypothesis was twofold:

1. By halving the size of each individual dose, I would lower the Cmax​ and thereby mitigate the GI side effects. This is a standard strategy for improving the tolerability of many substances.³¹
2. By administering a second dose 12 hours after the first, I would create a more sustained plasma concentration of resveratrol and its longer-lasting metabolites, extending the therapeutic window across the full 24-hour cycle. This approach was supported by at least one study that suggested a divided dose regimen for resveratrol.³⁸

This change immediately resolved the GI issues and felt more intellectually sound, as it aimed to optimize the total exposure (AUC) over time rather than just the initial peak.

Protocol v3.0 (The Chrono-Pharmacokinetic Refinement)

The final and current stage of my resveratrol protocol involved layering the principles of chronopharmacology and chrono-nutrition onto the split-dose strategy.

My research revealed that resveratrol is a lipophilic (fat-soluble) compound, and its absorption can be significantly influenced by the presence of food, particularly fats.³⁶

While some studies show conflicting results, the consensus leans toward improved or at least more consistent absorption when taken with a meal.³⁶

Dr. Sinclair himself reports taking his dose mixed with yogurt, a source of fat.⁴³

This led to my refined protocol: 500 mg of trans-resveratrol taken with my breakfast, which always includes healthy fats like olive oil or avocado, and another 500 mg taken with my evening meal. This strategy represents a synthesis of all the principles I had learned:

1. Enhance Bioavailability: Co-administration with dietary fats aims to improve the absorption of this lipophilic molecule.
2. Sustain Concentration: The split-dose schedule addresses the short half-life, providing a more continuous supply to the body.
3. Mitigate Side Effects: The lower individual doses prevent GI distress.
4. Align with Chrono-nutrition: Timing the doses with meals works in concert with the body’s natural feeding/fasting cycles, which are powerful synchronizers of peripheral clocks in the gut and liver.²⁴

While I continue to monitor the literature on advanced delivery systems like micronized powders, nanoemulsions, and co-administration with absorption enhancers like piperine, the human data remains either preliminary or, in the case of piperine, somewhat conflicting.³⁶

For now, this evidence-based, chrono-pharmacokinetic approach feels like the most rational and effective strategy.

3.2 NMN: Fueling the Engine in Time with its Rhythm

In contrast to resveratrol, nicotinamide mononucleotide (NMN) presents a different set of pharmacokinetic considerations.

As a direct precursor to the essential coenzyme NAD+, its primary role is to serve as a raw material, a fuel for the cellular engine.⁵⁵

Preclinical studies show that NMN is absorbed with remarkable speed, appearing in the bloodstream within minutes of oral administration and efficiently elevating NAD+ levels in various tissues.⁵⁶

While the half-life of NMN itself in humans is not yet well-defined, its downstream effect—the elevation of the NAD+ pool—is more sustained, with human studies showing significantly increased blood NAD+ levels after weeks of consistent supplementation.⁵⁷

Protocol v1.0 (The Sinclair Method)

My initial NMN protocol was, once again, a single 1 gram dose taken first thing in the morning, on an empty stomach.⁴³

The rationale for this timing is purely chronobiological.

The NAD+ pool and the activity of the NAD+-dependent sirtuin enzymes are not static; they exhibit a robust circadian rhythm, naturally peaking in the morning to support daytime activity and metabolism, and declining as the day progresses.⁶²

The logic of a single morning dose is to work

with this natural rhythm, amplifying the morning peak and providing a maximal supply of precursor fuel precisely when the cellular machinery is most active and ready to use it.⁴⁸

The Counterargument (The Sustained Fuel Hypothesis)

Despite the strong chronobiological argument, I had to consider an alternative hypothesis.

NAD+ is consumed by a multitude of processes throughout the entire 24-hour cycle, including DNA repair and other maintenance activities that may be more active during the nocturnal rest phase.

Could a single morning bolus be insufficient to maintain elevated NAD+ levels throughout the evening and night? This line of thinking would favor a split-dose regimen (e.g., 500 mg in the morning, 500 mg in the afternoon or evening) to provide a more constant supply of NMN precursor.

Indeed, at least one clinical trial protocol involving NMN supplementation in runners specified that the daily dose was split into two.⁶⁴

My Current Protocol and Justification

After weighing the evidence, I made the decision to maintain my single 1 gram morning dose of NMN.

My justification for this choice is a synthesis of the available clinical data and the principle of biological congruence:

1. Proven Clinical Efficacy: Multiple human clinical trials have demonstrated significant and meaningful benefits using a single daily morning dose. Studies using doses from 250 mg/day to 900 mg/day have shown significant increases in blood NAD+ levels, improved muscle insulin sensitivity, and enhanced physical performance and endurance.⁵⁹ A comprehensive dose-ranging study concluded that while efficacy increased up to 900 mg, the optimal balance of effect and dose was achieved around 600 mg/day, taken as a single morning administration.⁶⁰ The single-dose model is clinically validated.
2. Circadian Alignment: The primary goal of my protocol is to support and enhance the body’s natural, healthy rhythms, not to override them by creating an artificial, flat-line state of NAD+ availability. Amplifying the natural morning peak with a bolus dose seems more biologically congruent than attempting to flatten the curve with multiple doses. It reinforces the existing rhythm rather than potentially disrupting it.
3. Practicality and Adherence: While a secondary consideration, the simplicity of a single dose cannot be overstated. A protocol is only effective if it is followed consistently.

Regarding the method of administration, NMN is water-soluble and can be taken on an empty stomach for what is likely the most rapid absorption.⁴⁸

While there is an ongoing debate in the biohacking community about the superiority of sublingual or liposomal delivery, the vast majority of successful human clinical trials have used standard oral capsules or powders.⁶⁶

The evidence strongly supports that conventional oral administration is effective for raising systemic NAD+ levels, making more expensive and complex delivery methods unnecessary for most applications.⁵⁹

Chapter 4: Beyond Anecdote: A Systematic Review of the Evidence

While my personal N-of-1 experiments with NMN and resveratrol provided a valuable, practical education, I am a scientist first.

To truly validate the principles I was applying, I needed to move beyond my own experience and conduct a more objective, systematic review of the clinical literature.

My goal was to determine if the context-dependent nature of dosing strategy—where the “best” approach is dictated by the specific pharmacokinetic challenge of a given substance—was a broadly applicable principle of pharmacology.

The evidence I found was compelling and confirmed that the choice between single and split dosing is a nuanced decision that must be made on a case-by-case basis.

Case Study 1: Iron Supplementation – When Less (Frequent) is More

The conventional wisdom for treating iron deficiency has long been to recommend daily iron supplements, often split into multiple doses throughout the day to increase absorption and reduce side effects.⁷⁰

However, a landmark pair of randomized controlled trials challenged this dogma head-on.

The research revealed a fascinating interplay between iron dosing and the body’s own regulatory machinery.

• The Finding: The studies demonstrated that providing iron supplements on alternate days as a single morning dose resulted in significantly higher fractional iron absorption compared to giving the same or even a higher total dose daily, either as a single dose or split into two.⁷⁰
• The Mechanism: The key to this counterintuitive result lies in a hormone called hepcidin. When the body senses an influx of iron, the liver releases hepcidin, which acts to block further iron absorption from the gut. The studies showed that daily dosing, and particularly twice-daily split dosing, led to a sustained increase in serum hepcidin levels. This meant that the first dose was absorbed, but the subsequent dose 12 or 24 hours later was met with a wall of hepcidin, rendering it much less effective.⁷⁰ In contrast, dosing on alternate days provided a 48-hour window for hepcidin levels to fall back to baseline, “re-opening the gate” for maximal absorption from the next dose.
• The Takeaway: This is a powerful example where the body’s homeostatic feedback loops are the dominant factor in determining dosing strategy. Here, a less frequent single dose is demonstrably more effective than a split dose. It directly refutes the simplistic notion that maintaining sustained levels is always the optimal approach.

Case Study 2: Methotrexate for Rheumatoid Arthritis – Overcoming Saturation

Methotrexate (MTX) is a cornerstone therapy for rheumatoid arthritis (RA), but its oral bioavailability is known to be limited, especially at doses above 15 mg.⁷²

This presents a classic absorption saturation problem.

• The Finding: The SMART study, a multicenter randomized controlled trial, compared a single weekly 25 mg dose of oral MTX to a split dose (10 mg in the morning, 15 mg in the evening of the same day). The results were clear: the split-dose group showed significantly higher efficacy, including a greater EULAR good response and higher ACR20/50/70 response rates at 16 weeks. Crucially, fewer patients in the split-dose group required the addition of another disease-modifying drug.⁷²
• The Mechanism: The superiority of the split dose is almost certainly due to its ability to overcome the saturation of the intestinal transporters responsible for absorbing MTX. By breaking the large 25 mg dose into two smaller portions, the transport system is not overwhelmed, leading to a greater total fraction of the drug being absorbed and achieving higher, more effective blood levels.
• The Takeaway: This case perfectly illustrates the principle of absorption saturation. When a supplement or drug has a transport-limited absorption pathway, splitting the dose is not just an option—it is a necessity for achieving the intended therapeutic effect of a higher total daily dose.

Case Study 3: A Spectrum of Strategies

The principles extend to numerous other substances.

For some glucocorticoids used to treat sudden hearing loss, studies suggest a single daily dose may be more efficacious and, importantly, causes less suppression of the hypothalamic-pituitary-adrenal axis compared to a multiple divided-dose regimen.⁷³

Conversely, for nutrients with known absorption limits or those that cause GI distress at high concentrations, splitting the dose is the standard and evidence-backed recommendation.

This includes calcium, where absorption is capped at around 500-600 mg per administration ³⁰, and high-dose vitamin C, where splitting the dose can prevent osmotic diarrhea.³³

To synthesize these findings, the following table provides a comparative analysis, demonstrating how the specific pharmacokinetic challenge of a substance dictates the optimal dosing regimen.

Substance	Key Pharmacokinetic/Pharmacodynamic Challenge	Single Dose Regimen Studied	Split Dose Regimen Studied	Primary Outcome	Superior Regimen & Rationale	Source(s)
Iron	Inhibitory feedback loop via hepcidin upregulation with frequent dosing.	120 mg once daily or every other day.	60 mg twice daily.	Fractional iron absorption.	Single alternate-day dose. Avoids the sustained rise in hepcidin, allowing for greater absorption from each dose.	70
Methotrexate	Saturation of intestinal absorption transporters at doses >15 mg.	25 mg once weekly.	10 mg (AM) + 15 mg (PM) on the same day, once weekly.	EULAR good response; need for additional DMARDs.	Split dose. Overcomes absorption saturation, leading to higher bioavailability and greater clinical efficacy.	72
Glucocorticoids (for SSNHL)	Potential for HPA axis suppression; achieving high peak concentration.	1 mg/kg prednisolone once daily.	Total daily dose divided into multiple administrations.	Hearing recovery rate.	Single dose. Found to be more efficacious and causes less adrenal suppression.	73
Calcium	Saturation of absorption pathways (max ~500-600 mg at a time).	N/A (single large doses are known to be inefficient).	Doses of 500-600 mg or less, taken multiple times per day.	Total calcium absorption.	Split dose. Necessary to maximize total daily absorption by not overwhelming the transport system.	30
Vitamin C (high dose)	Dose-dependent gastrointestinal side effects (osmotic diarrhea).	Single large dose (e.g., >1,000 mg).	Multiple smaller doses throughout the day (e.g., 500 mg twice daily).	Tolerability; reduction of GI side effects.	Split dose. Lowers the peak concentration (Cmax​) in the gut, mitigating osmotic load and improving tolerability.	33

This comparative analysis solidifies the report’s central thesis.

It moves the discussion beyond my personal protocol and demonstrates that the strategic choice between single and split dosing is a fundamental principle of rational pharmacotherapy.

The data clearly show that when the limiting factor is a biological feedback mechanism like hepcidin, less frequent dosing can be superior.

When the limitation is absorption capacity or side effect tolerance, more frequent, split dosing is the logical choice.

There is no one-size-fits-all answer, only a series of principles to be intelligently applied.

Chapter 5: A Framework for a Personalized Chrono-Protocol

My journey through the literature and self-experimentation led me from a state of unconscious incompetence to one of conscious competence.

I had deconstructed the problem and identified the core principles.

The final step was to synthesize these principles into a practical, actionable framework—a decision-making tool that I, and others, could use to design a more rational and personalized supplementation protocol.

What follows is not medical advice, but rather a guide to the critical thinking process that I now apply to every component of my regimen.

The Decision Tree: Five Key Questions to Ask

For any supplement being considered, I now run it through a five-question decision tree.

The answers guide the ultimate choice between a single or split-dose strategy and inform the optimal timing of administration.

1. What is the supplement’s biological half-life (t1/2​)?

• This is the foundational question. A substance with a very short half-life (e.g., 1-4 hours), like resveratrol, is an immediate candidate for a split-dose regimen if the goal is sustained action. A substance with a long half-life (e.g., >24 hours), like vitamin D (which is stored in fat), can almost always be taken as a single daily dose without issue.²⁹

2. What is the primary mechanism of action?

• This question forces a consideration of the desired shape of the plasma concentration curve. Does the supplement act as a signaling molecule that requires a high peak concentration (Cmax​) to trigger a hormetic or adaptive response? If so, a single bolus dose might be preferable. Or does it act as a substrate or cofactor (like NMN for NAD+ synthesis) that is consumed continuously? If so, maintaining a stable, elevated steady-state level (optimizing AUC) via a split dose could be more logical.

3. Are there known absorption limits or saturation points?

• If the answer is yes, as it is for calcium and methotrexate, a split-dose regimen is strongly indicated.³⁰ Exceeding the absorption capacity with a single large dose is simply inefficient and wasteful. This requires researching the specific transport mechanisms of the molecule in question.

4. Is the supplement associated with dose-dependent side effects?

• For compounds known to cause issues like gastrointestinal distress at higher doses (e.g., resveratrol, iron, vitamin C, magnesium), splitting the dose is a primary strategy for mitigation.³¹ By lowering the
  Cmax​ of each individual administration, this approach almost always improves tolerability.

5. What is the relevant chronobiology?

• This is the final, most sophisticated layer of analysis. Does the biological target of the supplement (e.g., a receptor, an enzyme) have a known circadian rhythm? Does the body’s machinery for absorbing or metabolizing the supplement fluctuate predictably? The goal is to align the dosing schedule with these rhythms. This could mean taking a supplement in the morning to amplify a natural peak (as with NMN) or timing it with a meal to enhance absorption (as with fat-soluble resveratrol). This requires a deep dive into the chronopharmacology of the specific substance and its target pathway.⁷

Putting It All Together: My Refined Protocol as an Example

Applying this decision tree to my own regimen resulted in the following protocol.

It is a dynamic system, not a static list, and each decision is a deliberate one based on the principles outlined above.

• Morning (with a fat-containing breakfast):

• NMN (1 gram): Decision: Single dose. Rationale: The primary goal is circadian alignment. Human studies validate the efficacy of a single morning dose.⁶⁰ It amplifies the natural morning peak in NAD+ levels and sirtuin activity, working in concert with my body’s innate rhythm.⁴⁸
• Resveratrol (500 mg): Decision: First half of a split dose. Rationale: Addresses the short half-life and is taken with fats to maximize the absorption of this lipophilic compound.⁴⁰ This begins the process of establishing a sustained 24-hour presence.
• Evening (with dinner):

• Resveratrol (500 mg): Decision: Second half of a split dose. Rationale: This dose, taken approximately 12 hours after the first, counters the rapid clearance of resveratrol, maintaining more sustained levels of its metabolites overnight.⁴⁰ Taking it with the evening meal again leverages co-administration with fats for absorption.
• Magnesium (e.g., 200 mg glycinate): Decision: Split from other minerals and taken in the evening. Rationale: Magnesium can compete with minerals like zinc for absorption, so splitting them temporally is wise.³¹ The evening timing is chosen for its well-known role in promoting relaxation and supporting sleep quality, a chronodynamic consideration.

This protocol is a living document, subject to change as new research emerges.

However, the framework for making those changes is now robust.

The critical final step, of course, is the “N-of-1” validation.

This framework provides the hypothesis, but the proof comes from diligent self-experimentation coupled with objective biomarker tracking—regular blood tests, wearable data, and subjective feedback—to determine if the theoretical optimization translates into tangible biological results.

Conclusion: The Future is Timed

My journey into the science of supplement dosing began with a simple question and culminated in a complete paradigm shift.

I started with the conventional, convenient, but ultimately naive approach of a single morning bolus for all my supplements.

I have arrived at a nuanced, chronobiologically-informed strategy that treats my body not as a static container, but as a dynamic, rhythmic system.

The most profound lesson I have learned is this: in the complex pursuit of healthspan and longevity, when you do something is often as important as what you do.

The future of personalized medicine and intelligent supplementation, I am now convinced, lies not merely in the discovery of novel molecules or “longevity in a pill.” While new compounds will undoubtedly emerge, the next great leap forward will come from mastering the art and science of their delivery.

It will involve orchestrating the timing of these interventions to work in harmony with the ancient, innate biological rhythms that govern our physiology.⁷

We must move beyond a pharmacology of brute force and embrace a pharmacology of finesse—a chronotherapy that respects the body’s own clockwork.

This requires a new mindset for anyone serious about self-optimization.

I encourage you to view your own health protocol not as a fixed list of ingredients, but as a dynamic system of timed inputs.

Question the convenience of the “one-a-day” mentality.

Become a researcher in your own right.

For each supplement you take, ask the five key questions: What is its half-life? What is its mechanism? Are there absorption limits? What are the side effects? And what is the chronobiology? Use the principles of pharmacokinetics and chronopharmacology to design, test, and refine your own journey.

By aligning our interventions with the deep, biological tides that flow within us, we can unlock a new level of efficacy and truly begin to personalize the science of a longer, healthier life.

Works cited

1. Why Choose One A Day® Vitamins | One A Day®, accessed on August 7, 2025, https://www.oneaday.com/why-choose-one-a-day-vitamins
2. One A Day – Wikipedia, accessed on August 7, 2025, https://en.wikipedia.org/wiki/One_A_Day
3. Why Do Supplements Have High Daily Values? – Nature Made, accessed on August 7, 2025, https://www.naturemade.com/blogs/health-articles/why-do-supplements-have-high-daily-values
4. Why You Should Take a Daily Multivitamin | Piedmont Healthcare, accessed on August 7, 2025, https://www.piedmont.org/living-real-change/should-you-take-a-daily-multivitamin
5. Chronopharmacology: New Insights and Therapeutic Implications – PMC – PubMed Central, accessed on August 7, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC3885389/
6. IMPORTANCE OF CHRONOPHARMACOLOGY IN LIFESTYLE – ijprems.com, accessed on August 7, 2025, https://www.ijprems.com/uploadedfiles/paper/issue_12_december_2024/37559/final/fin_ijprems1733452760.pdf
7. Understanding the role of chronopharmacology for drug optimization: what do we know?, accessed on August 7, 2025, https://pubmed.ncbi.nlm.nih.gov/37403790/
8. The clinical impact of chronopharmacology on current medicine – PMC, accessed on August 7, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC12125046/
9. Unlocking Chronopharmacology Secrets – Number Analytics, accessed on August 7, 2025, https://www.numberanalytics.com/blog/ultimate-guide-chronopharmacology-clinical-pharmacology
10. CONCEPTS IN CHRONOPHARMACOLOGY – Annual Reviews, accessed on August 7, 2025, https://www.annualreviews.org/doi/pdf/10.1146/annurev.pa.32.040192.000411
11. Chronopharmacology: an insight into its knowledge among medical students, accessed on August 7, 2025, https://www.ijbcp.com/index.php/ijbcp/article/download/5178/3471/19663
12. Chronopharmacodynamics of drugs in toxicological aspects: A short review for clinical pharmacists and pharmacy practitioners – PMC, accessed on August 7, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC4076864/
13. Chronopharmacological strategies focused on chrono-drug discovery – PubMed, accessed on August 7, 2025, https://pubmed.ncbi.nlm.nih.gov/31173839/
14. International Journal of Research Publication and Reviews Chronopharmacology – ijrpr, accessed on August 7, 2025, https://ijrpr.com/uploads/V3ISSUE6/IJRPR5165.pdf
15. Chronopharmacokinetics: A Brief Analysis of the Influence of Circadian Rhythm on the Absorption, Distribution, Metabolism, and Elimination of Drugs. – Biomedical and Pharmacology Journal, accessed on August 7, 2025, https://biomedpharmajournal.org/vol17no3/chronopharmacokinetics-a-brief-analysis-of-the-influence-of-circadian-rhythm-on-the-absorption-distribution-metabolism-and-elimination-of-drugs/
16. (PDF) The clinical impact of chronopharmacology on current medicine – ResearchGate, accessed on August 7, 2025, https://www.researchgate.net/publication/387901826_The_clinical_impact_of_chronopharmacology_on_current_medicine
17. Chronopharmacokinetics: A Brief Analysis of the Influence of Circadian Rhythm on the Absorption, Distribution, Metabolism, and Elimination of Drugs – ResearchGate, accessed on August 7, 2025, https://www.researchgate.net/publication/384778814_Chronopharmacokinetics_A_Brief_Analysis_of_the_Influence_of_Circadian_Rhythm_on_the_Absorption_Distribution_Metabolism_and_Elimination_of_Drugs
18. An overview on chronopharmacology, accessed on August 7, 2025, https://www.wisdomlib.org/science/journal/world-journal-of-pharmaceutical-research/d/doc1383406.html
19. Chronopharmacological strategies focused on chrono-drug discovery | Request PDF – ResearchGate, accessed on August 7, 2025, https://www.researchgate.net/publication/333619946_Chronopharmacological_strategies_focused_on_chrono-drug_discovery
20. Chronopharmacology: Optimizing drug therapy through biological rhythms – National Journal of Physiology, Pharmacy and Pharmacology, accessed on August 7, 2025, https://www.njppp.com/index.php?fulltxt=216763&fulltxtj=28&fulltxtp=28-1724332189.pdf
21. [Chronopharmacology and chronotherapy of cancers] – PubMed, accessed on August 7, 2025, https://pubmed.ncbi.nlm.nih.gov/8977920/
22. Nutrients | Special Issue : Chrononutrition and Chronic Diseases – MDPI, accessed on August 7, 2025, https://www.mdpi.com/journal/nutrients/special_issues/Chrononutrition
23. Understanding the Interplay Between Circadian Rhythms and Personalized Nutrition, accessed on August 7, 2025, https://www.youtube.com/watch?v=ZTccDMNIpxY
24. Chrono-Nutrition: Circadian Rhythm and Personalized Nutrition – PMC – PubMed Central, accessed on August 7, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9916946/
25. Drug Bioavailability – StatPearls – NCBI Bookshelf, accessed on August 7, 2025, https://www.ncbi.nlm.nih.gov/books/NBK557852/
26. Chapter 1 Pharmacokinetics & Pharmacodynamics – Nursing Pharmacology – NCBI, accessed on August 7, 2025, https://www.ncbi.nlm.nih.gov/books/NBK595006/
27. Drug Bioavailability – Clinical Pharmacology – Merck Manual Professional Edition, accessed on August 7, 2025, https://www.merckmanuals.com/professional/clinical-pharmacology/pharmacokinetics/drug-bioavailability
28. Pharmacology, Part 2: Introduction to Pharmacokinetics, accessed on August 7, 2025, https://tech.snmjournals.org/content/46/3/221
29. Biological half-life – Wikipedia, accessed on August 7, 2025, https://en.wikipedia.org/wiki/Biological_half-life
30. Calcium/Vitamin D Requirements, Recommended Foods & Supplements – Bone Health & Osteoporosis Foundation, accessed on August 7, 2025, https://www.bonehealthandosteoporosis.org/patients/treatment/calciumvitamin-d/
31. What to Know About Supplement Dosing and Interactions – Institute …, accessed on August 7, 2025, https://naturemed.org/what-to-know-about-supplement-dosing-and-interactions/
32. The Common Mistakes to Avoid When Taking Diet Gummies – Mississippi Valley State University, accessed on August 7, 2025, https://www.mvsu.edu/sites/default/files/webform/the-common-mistakes-to-avoid-when-taking-diet-gummies-aagh83.html
33. Morning vs. Evening Supplements: How Do They Compare?, accessed on August 7, 2025, https://www.verywellhealth.com/is-it-better-to-take-supplements-in-the-morning-or-at-night-11760365
34. Methotrexate: Managing Side Effects – Arthritis Foundation, accessed on August 7, 2025, https://www.arthritis.org/health-wellness/treatment/treatment-plan/disease-management/methotrexate-managing-side-effects
35. Resveratrol in prevention and treatment of common clinical conditions of aging – PMC, accessed on August 7, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC2546476/
36. Resveratrol Delivery – News-Medical.net, accessed on August 7, 2025, https://www.news-medical.net/health/Resveratrol-Delivery.aspx
37. The journey of resveratrol from yeast to human – Aging-US, accessed on August 7, 2025, https://www.aging-us.com/article/100445/text
38. Trans-Resveratrol Oral Bioavailability in Humans Using LipiSperse™ Dispersion Technology – PMC, accessed on August 7, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC7763804/
39. Resveratrol | Linus Pauling Institute, accessed on August 7, 2025, https://lpi.oregonstate.edu/mic/dietary-factors/phytochemicals/resveratrol
40. Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers – ResearchGate, accessed on August 7, 2025, https://www.researchgate.net/publication/229504013_Pharmacokinetic_and_safety_profile_of_trans-resveratrol_in_a_rising_multiple-dose_study_in_healthy_volunteers
41. High Absorption but Very Low Bioavailability of Oral Resveratrol in Humans – ResearchGate, accessed on August 7, 2025, https://www.researchgate.net/publication/8377897_High_Absorption_but_Very_Low_Bioavailability_of_Oral_Resveratrol_in_Humans
42. Resveratrol – Wikipedia, accessed on August 7, 2025, https://en.wikipedia.org/wiki/Resveratrol
43. David Sinclair Supplement Routine | 2024 Scientific Review – NOVOS, accessed on August 7, 2025, https://novoslabs.com/best-anti-aging-supplements-that-harvard-scientist-david-sinclair-takes/
44. Reviewing Dr. David Sinclair’s Supplement Regimen in 2025 – Jinfiniti, accessed on August 7, 2025, https://www.jinfiniti.com/david-sinclair-supplements/
45. Resveratrol Uses, Benefits & Dosage – Drugs.com, accessed on August 7, 2025, https://www.drugs.com/npp/resveratrol.html
46. Resveratrol Gastrointestinal Side Effects – Consensus, accessed on August 7, 2025, https://consensus.app/search/does-resveratrol-cause-gastrointestinal-issues-at-/Q3xA2_CxQbCaTfJWHk5xlA/
47. Resveratrol – Memorial Sloan Kettering Cancer Center, accessed on August 7, 2025, https://www.mskcc.org/cancer-care/integrative-medicine/herbs/resveratrol
48. Best Times to Take NMN and Resveratrol – Decode Age, accessed on August 7, 2025, https://decodeage.com/blogs/supplements/best-times-to-take-nmn-and-resveratrol
49. Effect of food on the pharmacokinetic profile of trans-resveratrol – PubMed, accessed on August 7, 2025, https://pubmed.ncbi.nlm.nih.gov/19000554/
50. Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol – MDPI, accessed on August 7, 2025, https://www.mdpi.com/1422-0067/20/6/1381
51. Enhancing the bioavailability of resveratrol by combining it with piperine, accessed on August 7, 2025, https://www.periodicos.capes.gov.br/index.php/acervo/buscador.html?task=detalhes&id=W2057355419
52. Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in human subjects: a randomised, double-blind, placebo-controlled, cross-over investigation | British Journal of Nutrition – Cambridge University Press, accessed on August 7, 2025, https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/effects-of-resveratrol-alone-or-in-combination-with-piperine-on-cerebral-blood-flow-parameters-and-cognitive-performance-in-human-subjects-a-randomised-doubleblind-placebocontrolled-crossover-investigation/772AD010D210C0394A4EBE9C90C8B7C6
53. A Randomized, Double-Blind, Dose-Ranging, Pilot Trial of Piperine with Resveratrol on the Effects on Serum Levels of Resveratrol, accessed on August 7, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC7910313/
54. A randomized, double-blind, dose-ranging, pilot trial of piperine with resveratrol on the effects on serum levels of resveratrol | Request PDF – ResearchGate, accessed on August 7, 2025, https://www.researchgate.net/publication/343985403_A_randomized_double-blind_dose-ranging_pilot_trial_of_piperine_with_resveratrol_on_the_effects_on_serum_levels_of_resveratrol
55. Nicotinamide mononucleotide – Wikipedia, accessed on August 7, 2025, https://en.wikipedia.org/wiki/Nicotinamide_mononucleotide
56. The Science Behind NMN–A Stable, Reliable NAD+Activator and Anti-Aging Molecule, accessed on August 7, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC7238909/
57. Benefits of NMN supplementation: From day 1 to 6 months – Elysium Health, accessed on August 7, 2025, https://www.elysiumhealth.com/blogs/aging101/benefits-of-nmn
58. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men – J-Stage, accessed on August 7, 2025, https://www.jstage.jst.go.jp/article/endocrj/67/2/67_EJ19-0313/_html/-char/en
59. Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects – PMC, accessed on August 7, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9036060/
60. The efficacy and safety of β-nicotinamide mononucleotide (NMN …, accessed on August 7, 2025, https://pubmed.ncbi.nlm.nih.gov/36482258/
61. Effective NMN Dosage Guide: How Much to Take Daily | Wonderfeel, accessed on August 7, 2025, https://getwonderfeel.com/how-much-nmn-raise-nad-levels/
62. NMN and Resveratrol Benefits: Can You Take Them Together? – Jinfiniti, accessed on August 7, 2025, https://www.jinfiniti.com/nmn-and-resveratrol-benefits-together/
63. NMN Dosage Guide: How to Safely Take NMN – Jinfiniti, accessed on August 7, 2025, https://www.jinfiniti.com/nmn-dosage/
64. Nicotinamide Mononucleotide (NMN) – Regulations.gov, accessed on August 7, 2025, https://downloads.regulations.gov/FDA-2022-S-0023-0029/content.pdf
65. 4 Reasons You May Want To Take Nicotinamide Mononucleotide (aka NMN) – Health, accessed on August 7, 2025, https://www.health.com/nmn-benefits-7550396
66. Is NMN well absorbed as oral capsules? Is there anything I should know about NMN in capsule form? – NOVOS, accessed on August 7, 2025, https://novoslabs.com/frequently-asked-questions/nmn-nicotinamide-mononucleotide/nnm-is-known-to-have-oral-delivery-issues-how-do-you-deal-with-that/
67. Can You Take NMN Orally? Or Only Sublingually? – NOVOS, accessed on August 7, 2025, https://novoslabs.com/can-you-take-nmn-orally-or-only-sublingually/
68. Why SubQ or IM NAD+ is Highly Disadvantageous Compared to Sublingual Biofermented NMN | Dripdok Help Center – Intercom, accessed on August 7, 2025, https://intercom.help/dripdok/en/articles/10489441-why-subq-or-im-nad-is-highly-disadvantageous-compared-to-sublingual-biofermented-nmn
69. Pharmacokinetics and bioavailability of NMN oral formulations – Consensus, accessed on August 7, 2025, https://consensus.app/search/pharmacokinetics-and-bioavailability-of-nmn-oral-f/_OwFKkZJQKOKSC0bdCZPlA/
70. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: Two open-label, randomised controlled trials | Request PDF – ResearchGate, accessed on August 7, 2025, https://www.researchgate.net/publication/320367972_Iron_absorption_from_oral_iron_supplements_given_on_consecutive_versus_alternate_days_and_as_single_morning_doses_versus_twice-daily_split_dosing_in_iron-depleted_women_Two_open-label_randomised_contr
71. What is the recommended oral iron supplementation regimen for patients with iron deficiency anemia? – Dr.Oracle, accessed on August 7, 2025, https://www.droracle.ai/articles/168041/oral-iron-supplementation
72. Comparison of Two Dosing Schedules for Oral Methotrexate (Split-Dose versus Single-Dose) Once Weekly in Patients with Active Rheumatoid Arthritis: A Multicenter, Open Label, Parallel Group, Randomized Controlled Trial (SMART Study) – ACR Meeting Abstracts, accessed on August 7, 2025, https://acrabstracts.org/abstract/comparison-of-two-dosing-schedules-for-oral-methotrexate-split-dose-versus-single-dose-once-weekly-in-patients-with-active-rheumatoid-arthritis-a-multicenter-open-label-parallel-group-randomized/
73. A comparison of single-dose and multiple divided daily-dose oral steroids for sudden sensorineural hearing loss | Brazilian Journal of Otorhinolaryngology, accessed on August 7, 2025, https://www.bjorl.org/en-a-comparison-single-dose-multiple-divided-articulo-S1808869418304257
74. Importance of Circadian Rhythm in Drug Administration Timing – Chronobiology in Medicine, accessed on August 7, 2025, https://www.chronobiologyinmedicine.org/journal/view.php?number=133
75. Chronopharmacology in Therapeutic Drug Monitoring—Dependencies between the Rhythmics of Pharmacokinetic Processes and Drug Concentration in Blood – MDPI, accessed on August 7, 2025, https://www.mdpi.com/1999-4923/13/11/1915